UnitedHealth (UNH) shares rose after a strong Q3 report, beating expectations and raising full-year guidance. Adjusted earnings are now projected at $16.25 per share for 2025, up from $16. The company’s strategic initiatives are paying off, with strong cash flow and a target for double-digit growth by 2027. The stock is up 60% from its August low.

Options traders are bullish on UnitedHealth, pricing for continued upside. Contracts expiring in January suggest a potential 10.3% increase to $413. Short-term expectations also point to a possible rise to $391 by November 7. The company’s diversified business model and market leadership position it well for further growth.

Wall Street firms maintain a “Moderate Buy” rating on UnitedHealth with price targets up to $440, indicating an 18% potential upside. The company’s positive quarterly release has bolstered confidence in its future performance. Overall, UnitedHealth remains a strong investment opportunity with room for growth in the coming years.

Read more at Barchart: UnitedHealth Reported Rising Revenue. Options Data Tells Us Where UNH Stock Could Be Headed Next.